ARTE Corporation

What ARTE Corporation does

ARTE Corporation is a privately-held Japanese manufacturer of pharmaceutical primary packaging, founded in September 1947 as Yokoshima Rikagaku and renamed to its present form in July 1990. The company produces prefillable syringes (single-chamber and dual-chamber variants), glass ampoules, glass cartridges, glass vials, and vial caps, all manufactured at a single integrated site in Takahagi City, Ibaraki Prefecture, with additional warehouse capacity in Kaminoyama City, Yamagata Prefecture. Core technology is built around pharmaceutical-grade USP Type I glass with silicone baking finishes for stable slideability, vertically integrated clean-room manufacturing, WFI production, and EOG sterilization, supporting regulatory compliance including FDA Drug Master File registrations and China NMPA registrations for prefilled syringes and glass ampoules.

The company holds an exclusive license from Solvay Pharmaceuticals B.V. (formerly Duphar B.V.) for the manufacture of Prefillable® Syringes, dating to June 1990, and has developed proprietary dual-chamber syringe technology enabling powder/liquid combinations and freeze-dried formulations. Products are sold exclusively through direct B2B channels to pharmaceutical manufacturers on a quote-based pricing model, with no public pricing, e-commerce, or self-serve channels. Customer end-uses span vaccines, oncology treatments, schizophrenia medications, osteoarthritis therapies, diluents, and freeze-dried formulations.

ARTE generates revenue through hardware sales of these container systems and assembled kits, with components available individually to support customer fill-finish processes. The company is led by President and Representative Director Seiji Shimazaki, has maintained capital of 288 million yen since 2002 with no external funding rounds disclosed, and is independently owned. Recent strategic activity centers on capacity expansion (solar power phases, QC building), new product introduction (sterile packaged ready-to-fill glass vials in 2026), and broadening of medical-device quality certifications (ISO 13485:2016 in 2022).

Name

ARTE Corporation

Legal name

株式会社アルテ

Website

https://artecorp.co.jp

Company type

Private

Founded year

1947

Operating status

Operating

Short description

ARTE Corporation is a privately-held Japanese manufacturer of pharmaceutical primary packaging, producing prefillable syringes, glass ampoules, vials, and cartridges at its Takahagi plant and selling directly to pharmaceutical manufacturers on a B2B basis under FDA and China NMPA registrations.

Ownership category

akta.pro rank

Product category

Pharmaceutical Packaging

NAICS

Glass Container Manufacturing (327213), Other Pressed and Blown Glass and Glassware Manufacturing (327212)

SIC

Glass Containers (3221), Glass & Glassware, Pressed Or Blown (3220)

akta.pro primary industry

Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB)

akta.pro secondary industries

Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes) (IMALAIAF)

Keywords

• Pharmaceutical container manufacturing
• Prefillable syringe systems
• Glass ampoule production
• Sterile vial packaging
• Pharmaceutical glass packaging

Headquarters

HQ city

Shinagawa-ku, Tokyo

HQ country

Japan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Container Manufacturing and Sales: Manufactures and sells pharmaceutical containers including prefillable syringes, ampoules, vials, and glass cartridges to pharmaceutical companies. Revenue is generated through product sales, with components available individually or as assembled kits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

ARTE Corporation manufactures pharmaceutical glass containers including prefillable syringes (single-chamber and dual-chamber), glass ampoules, glass cartridges, sterile packaged ready-for-filling vials (Nest and Tub format), and vials with vial caps. All products are 100% manufactured in Japan at the Takahagi plant under strict quality control and ISO 13485:2016 certified quality management, sold directly to pharmaceutical manufacturers for use in injectable drugs, vaccines, and freeze-dried formulations.

Product overview

ARTE Corporation is a manufacturer of pharmaceutical containers offering six core product lines: ARTE Prefillable® Syringes (available as single-chamber and dual-chamber configurations), Sterile packaged ready for filling glass vials (nest and tab format), Glass ampoules/Glass cartridges, and Vials/vial caps. The company provides both bulk products and assembled products, with some syringes available in nest and tub or package strip formats. Products are manufactured under ISO 13485 quality management systems with 100% domestic (Japan) production.

Differentiator

Problem solved

Functional benefit

Products and services

• ARTE Prefillable® Syringes Prefillable syringe system developed at the request of medical institutions and manufactured under exclusive license from Duphar B.V./Solvay Pharmaceuticals B.V. Features one-touch safe usage eliminating the need to puncture rubber stoppers, removing coring concerns. Components can be supplied separately for flexible manufacturing process design. Available in single-chamber and dual-chamber configurations for pharmaceutical manufacturers.
• Single-chamber Prefillable® Syringe Most typical ARTE prefillable syringe configuration filled with one-component medicine. Cap or injection needle can be selected. Used for vaccines, sodium hyaluronate, and freeze-dried formulations. Filler content range: 0.25mL to 5mL.
• Dual-chamber Prefillable® Syringe Syringe with two chambers for filling with two types of medicines; can be filled with powder formulation and solution, with freeze-drying capability after filling the front chamber. Supports attachment of hub luer lock or finger grip to glass cartridge. Filler content: Front chamber 1mL to 4mL, Rear chamber 1mL to 3mL.
• Sterile packaged ready for filling glass vials Nest and Tub Sterile Vials manufactured at ARTE Takahagi Plant using the same equipment as pharmaceutical companies for vial washing and dry heat sterilization. Compliant with ISO 8362-1:2018, double-wrapped in EOG sterilization pouches compliant with ISO 21882:2019. Reduces customer labor costs, maintenance expenses, and energy consumption by eliminating need for in-house vial sterilization infrastructure.
• Glass ampoules / Glass cartridges Glass ampoules manufactured with USP Type I pharmaceutical glass under strict quality control. Available in clear and amber (light shielding) variants, volume ranges 1mL to 20mL, with options for sulfur and silicone internal processing. Glass cartridges designed to withstand difficult usage conditions such as dental anesthesia injections.
• Vials / vial caps Glass vials with volume ranges from 2mL to 50mL, available for liquids and freeze-drying applications. Vial caps available in various types and sizes. Printing and customization available upon request for pharmaceutical manufacturer specifications.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Solvay Pharmaceuticals B.V. (formerly Duphar B.V.)coreOEM/ Whitelabel/ Licensing Partner · 1 June 1990Exclusive license agreement for manufacture of Prefillable® Syringes. ARTE obtained the exclusive license from Duphar B.V. (now Solvay Pharmaceuticals B.V.) in June 1990, enabling ARTE to manufacture and sell prefillable syringes under this technology.

Scale indicators4 records

Recent moves8 records

Expansion highlights3 records

Direct peers

• Gerresheimer AG: German-headquartered global manufacturer of pharmaceutical glass and plastic packaging, including prefillable syringes, vials, ampoules, and cartridges. Most directly comparable to ARTE as a primary container supplier to pharma companies, but at substantially larger scale and broader geographic footprint.
• Schott AG: German manufacturer of pharmaceutical glass including syringes, vials, cartridges, and ampoules under Schott Pharma. Highly comparable to ARTE in product portfolio (prefillable syringes, vials, glass cartridges) and serves the same injectable drug customer base, with significantly larger scale.
• Stevanato Group: Italian manufacturer of pharmaceutical glass containers and integrated drug delivery systems including prefillable syringes, vials, and drug containment solutions. Directly competes with ARTE in glass syringes and vials for injectable drugs.
• Nipro Corporation: Japanese-headquartered manufacturer of medical devices and pharmaceutical packaging including glass tubing, vials, ampoules, and prefillable syringes. Closest Japanese peer to ARTE, with overlapping customer base and product portfolio but materially larger scale and broader product breadth.
• West Pharmaceutical Services: US-based manufacturer of elastomeric components, seals, and integrated containment and delivery systems for injectable drugs, including prefillable syringe and cartridge components. Comparable to ARTE on the prefillable syringe system side, though specializing in elastomeric and plastic components rather than glass.

Broad incumbents

• Becton Dickinson (BD): US-listed medical technology company whose Pharmaceutical Systems segment manufactures prefillable syringe systems, vials, and drug delivery devices. Significantly larger and more diversified than ARTE, but directly comparable on the prefillable syringe product line.
• Corning Incorporated: US-based materials science company with a Life Sciences segment producing pharmaceutical glass (Valor Glass) for vials and syringes. Overlaps with ARTE in pharmaceutical primary packaging glass but at vastly greater scale and with proprietary glass composition technology.
• DWK Life Sciences: Global manufacturer of laboratory and pharmaceutical glassware including vials, ampoules, and primary packaging. Comparable product overlap with ARTE in glass ampoules and vials, but with broader portfolio spanning laboratory and life science consumables.

Emerging players

• Samsung Biologics / Genuvia (pharma packaging): South Korean conglomerate-affiliated pharmaceutical packaging manufacturer producing vials and syringes for injectable drugs. Comparable in scale to ARTE, serves the same pharmaceutical customer segment, and represents an emerging Asian competitor in primary packaging glass.
• Ampulla / Adelphi Healthcare Packaging: UK-based specialist supplier of pharmaceutical glass packaging including vials, ampoules, and prefillable syringe components. Comparable niche player to ARTE in primary packaging for injectable drugs, though smaller and more distribution-focused than manufacturing-focused.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARTE Corporation